Breaking News, Collaborations & Alliances

Fina Biosolutions Selects Scorpius for cGMP Production of CRM197

Partnership includes recovery and downstream process optimization, and cGMP bulk drug substance manufacturing of CRM197.

Fina Biosolutions has selected Scorpius BioManufacturing, a biologics CDMO, for the production of an E.coli-expressed CRM197 conjugate vaccine carrier protein. The partnership includes recovery and downstream process optimization, analytical method implementation and phase-appropriate validation, scale-up, and cGMP bulk drug substance manufacturing of CRM197, a genetically detoxified diphtheria toxin widely used in conjugate vaccines. FinaBio markets their CRM197 under the tradename EcoCRM. ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters